About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
About Company Profile Business Strategies Management Team Technology Consultant R & D Pipeline CAL056 CAL002 CAL005 News Contact
Company Profile Business Strategies Management Team Technology Consultant
Pipeline CAL056 CAL002 CAL005
分類: NEWS
CALGENT participated in 2022 US BIO that held in San Diego, June 13th ~ 16th with Taiwan MOST. Calgent demonstrated strong energy in R&D to the international market and increased the attention of international pharmaceutical companies for CAL056 Mesylate.
HEAD OFFICE 24F., No. 1, Songzhi Rd., Xinyi Dist., Taipei City 11047, Taiwan (R.O.C.) Tel: +886-2-2732-2782 Fax: +886-2-2732-5502
CALGENT LAB 32F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 22175, Taiwan (R.O.C.) Tel: +886-2-2732-2782
About R & D News Contact
©2025 Calgent Biotechnology Co. Ltd. All rights reserved. 網頁設計公司:振作國際